AcelRx Pharmaceuticals Inc. (ACRX)

1.90
NASDAQ : Health Technology
Prev Close 1.75
Day Low/High 1.80 / 1.90
52 Wk Low/High 1.55 / 5.75
Avg Volume 470.20K
Exchange NASDAQ
Shares Outstanding 50.34M
Market Cap 85.57M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We exited one position and added to another as volatility returned to the stock market last week.

Stocks Under $10 Weekly Summary

It was a mixed week for the portfolio as we trimmed one position and added to the Bullpen.

Stocks Under $10 Weekly Summary

Last week, we closed a position for a large gain and used some of the proceeds to start a small stake in a fracking and desalination name.

Stocks Under $10 Weekly Summary

We added two new positions to the portfolio last week.

Stocks Under $10 Weekly Summary

Despite a shortened trading week, we made a series of moves, including initiating a position in GSV Capital.

Stocks Under $10 Weekly Summary

During a quiet week for the market, we added to two positions and trimmed three others.

Adding to and Trimming Different Biotechs

We will buy more AcelRx Pharmaceuticals and sell shares of Inovio Pharmaceuticals as we close out 2017.

Stocks Under $10 Weekly Summary

During another busy week, we rang the register and exited our position in Amplify, trimmed another name twice and scaled into a recent addition.

Stocks Under $10 Weekly Summary

Last week was a busy one for the portfolio, as we made a number of trades and saw outsized gains in several positions.

Stocks Under $10 Weekly Summary

We bought into some tech names last week as a rotation occurred in the sector.

Stocks Under $10 Weekly Summary

For the second week in a row, we initiated a new position, this time in a security tech name.

Stocks Under $10 Weekly Summary

We initiated a new position for the portfolio during the shortened holiday trading week.

Stocks Under $10 Weekly Summary

We exited three biotech/pharma positions and added to two other holdings during a busy week for the portfolio.

Stocks Under $10 Weekly Summary

We exited two positions today following a tough week for small-cap stocks.

Cutting Inovio Pharma's Rating

We are looking to exit this name, maximizing exit value.

Adding to a Pharma Position, and an Update on Portfolio Earnings

Earnings analysis on four stocks -- and we are increasing our ACRX position on this weakness.

Stocks Under $10 Weekly Summary

Last week, we increased our holdings in one position and added 2 Bullpen names.

Stocks Under $10 Weekly Summary

We used price declines to scale into several holdings as small-caps underperformed the overall market.

What Enzo Biochem's Good News Means for Our Position

Keep a close eye on this one, and establish a stop-loss order at or around $9.50.

Stocks Under $10 Weekly Summary

This week brings earnings from 5 portfolio holdings as the market continues to shrug off potential negatives.

Adding to a Health Care Name

We have to purchase some AcelRx Pharmaceuticals to take advantage of these prices.

Staying on Top of Hudson Technologies

Our plan of action on HDSN and our new price target.

Stocks Under $10 Weekly Summary

We took some profits and added a Bullpen name, among other moves, during a rough week for a few portfolio names.

TheStreet Quant Rating: D- (Sell)